nodes	percent_of_prediction	percent_of_DWPC	metapath
Clomipramine—GSTP1—Parkinson's disease	0.376	0.486	CbGaD
Clomipramine—HTR2A—Parkinson's disease	0.155	0.2	CbGaD
Clomipramine—CYP2D6—Parkinson's disease	0.142	0.183	CbGaD
Clomipramine—ABCB1—Parkinson's disease	0.101	0.131	CbGaD
Clomipramine—SLC6A2—locus ceruleus—Parkinson's disease	0.00535	0.0625	CbGeAlD
Clomipramine—HTR2A—enteric nervous system—Parkinson's disease	0.00487	0.0569	CbGeAlD
Clomipramine—SLC6A2—sympathetic nervous system—Parkinson's disease	0.00423	0.0494	CbGeAlD
Clomipramine—HTR2A—myenteric nerve plexus—Parkinson's disease	0.00369	0.0431	CbGeAlD
Clomipramine—HTR2A—locus ceruleus—Parkinson's disease	0.00321	0.0376	CbGeAlD
Clomipramine—HTR2C—telencephalic ventricle—Parkinson's disease	0.00304	0.0355	CbGeAlD
Clomipramine—SLC6A2—autonomic nervous system—Parkinson's disease	0.00284	0.0332	CbGeAlD
Clomipramine—HTR2A—cerebellar cortex—Parkinson's disease	0.00262	0.0306	CbGeAlD
Clomipramine—HTR2A—sympathetic nervous system—Parkinson's disease	0.00254	0.0297	CbGeAlD
Clomipramine—HTR2A—pons—Parkinson's disease	0.00185	0.0217	CbGeAlD
Clomipramine—HTR2A—autonomic nervous system—Parkinson's disease	0.00171	0.02	CbGeAlD
Clomipramine—SLC6A2—nerve—Parkinson's disease	0.0016	0.0187	CbGeAlD
Clomipramine—HTR2A—telencephalic ventricle—Parkinson's disease	0.00152	0.0178	CbGeAlD
Clomipramine—ADRA2A—peripheral nervous system—Parkinson's disease	0.00145	0.0169	CbGeAlD
Clomipramine—HTR6—forebrain—Parkinson's disease	0.00137	0.0161	CbGeAlD
Clomipramine—SLC6A4—hindbrain—Parkinson's disease	0.00136	0.0159	CbGeAlD
Clomipramine—HTR2A—peripheral nervous system—Parkinson's disease	0.00123	0.0144	CbGeAlD
Clomipramine—HRH2—cardiovascular system—Parkinson's disease	0.00106	0.0124	CbGeAlD
Clomipramine—GSTP1—embryo—Parkinson's disease	0.00102	0.012	CbGeAlD
Clomipramine—HTR2A—nerve—Parkinson's disease	0.00096	0.0112	CbGeAlD
Clomipramine—GSTP1—forebrain—Parkinson's disease	0.000904	0.0106	CbGeAlD
Clomipramine—HTR2C—brainstem—Parkinson's disease	0.000822	0.00961	CbGeAlD
Clomipramine—HTR2C—forebrain—Parkinson's disease	0.000793	0.00928	CbGeAlD
Clomipramine—HTR6—head—Parkinson's disease	0.000786	0.00919	CbGeAlD
Clomipramine—SLC6A4—brainstem—Parkinson's disease	0.000779	0.00911	CbGeAlD
Clomipramine—GSTP1—cardiovascular system—Parkinson's disease	0.000764	0.00894	CbGeAlD
Clomipramine—SLC6A4—forebrain—Parkinson's disease	0.000752	0.0088	CbGeAlD
Clomipramine—HTR6—nervous system—Parkinson's disease	0.000745	0.00872	CbGeAlD
Clomipramine—HTR2B—forebrain—Parkinson's disease	0.000745	0.00872	CbGeAlD
Clomipramine—HTR2A—hindbrain—Parkinson's disease	0.000719	0.00841	CbGeAlD
Clomipramine—HRH2—head—Parkinson's disease	0.000719	0.00841	CbGeAlD
Clomipramine—HTR6—central nervous system—Parkinson's disease	0.000717	0.00839	CbGeAlD
Clomipramine—SLC6A2—brainstem—Parkinson's disease	0.000686	0.00802	CbGeAlD
Clomipramine—HRH2—nervous system—Parkinson's disease	0.000681	0.00797	CbGeAlD
Clomipramine—SLC6A2—forebrain—Parkinson's disease	0.000662	0.00774	CbGeAlD
Clomipramine—HRH2—central nervous system—Parkinson's disease	0.000656	0.00767	CbGeAlD
Clomipramine—CYP2D6—hindbrain—Parkinson's disease	0.000655	0.00767	CbGeAlD
Clomipramine—GSTP1—medulla oblongata—Parkinson's disease	0.000653	0.00764	CbGeAlD
Clomipramine—HTR2B—cardiovascular system—Parkinson's disease	0.00063	0.00737	CbGeAlD
Clomipramine—GSTP1—midbrain—Parkinson's disease	0.000597	0.00698	CbGeAlD
Clomipramine—GSTP1—spinal cord—Parkinson's disease	0.000582	0.00681	CbGeAlD
Clomipramine—HTR2C—medulla oblongata—Parkinson's disease	0.000573	0.0067	CbGeAlD
Clomipramine—HTR6—brain—Parkinson's disease	0.00057	0.00666	CbGeAlD
Clomipramine—HTR2C—midbrain—Parkinson's disease	0.000524	0.00613	CbGeAlD
Clomipramine—HRH2—brain—Parkinson's disease	0.000521	0.00609	CbGeAlD
Clomipramine—GSTP1—head—Parkinson's disease	0.000517	0.00605	CbGeAlD
Clomipramine—HTR2C—spinal cord—Parkinson's disease	0.000511	0.00598	CbGeAlD
Clomipramine—SLC6A4—midbrain—Parkinson's disease	0.000497	0.00581	CbGeAlD
Clomipramine—GSTP1—nervous system—Parkinson's disease	0.000491	0.00574	CbGeAlD
Clomipramine—SLC6A4—spinal cord—Parkinson's disease	0.000484	0.00567	CbGeAlD
Clomipramine—SLC6A2—medulla oblongata—Parkinson's disease	0.000478	0.00559	CbGeAlD
Clomipramine—GSTP1—central nervous system—Parkinson's disease	0.000472	0.00552	CbGeAlD
Clomipramine—ADRA2A—forebrain—Parkinson's disease	0.000468	0.00547	CbGeAlD
Clomipramine—GSTP1—cerebellum—Parkinson's disease	0.000462	0.0054	CbGeAlD
Clomipramine—HTR2C—head—Parkinson's disease	0.000454	0.00531	CbGeAlD
Clomipramine—HTR2A—embryo—Parkinson's disease	0.00045	0.00526	CbGeAlD
Clomipramine—HTR2C—nervous system—Parkinson's disease	0.000431	0.00504	CbGeAlD
Clomipramine—SLC6A4—head—Parkinson's disease	0.000431	0.00504	CbGeAlD
Clomipramine—HTR2B—head—Parkinson's disease	0.000427	0.00499	CbGeAlD
Clomipramine—HTR2C—central nervous system—Parkinson's disease	0.000415	0.00485	CbGeAlD
Clomipramine—HTR2A—brainstem—Parkinson's disease	0.000412	0.00482	CbGeAlD
Clomipramine—SLC6A4—nervous system—Parkinson's disease	0.000408	0.00477	CbGeAlD
Clomipramine—HTR2B—nervous system—Parkinson's disease	0.000404	0.00473	CbGeAlD
Clomipramine—HTR2A—forebrain—Parkinson's disease	0.000398	0.00465	CbGeAlD
Clomipramine—SLC6A4—central nervous system—Parkinson's disease	0.000393	0.0046	CbGeAlD
Clomipramine—HTR2B—central nervous system—Parkinson's disease	0.000389	0.00456	CbGeAlD
Clomipramine—SLC6A2—head—Parkinson's disease	0.000379	0.00443	CbGeAlD
Clomipramine—CYP2D6—brainstem—Parkinson's disease	0.000376	0.00439	CbGeAlD
Clomipramine—GSTP1—brain—Parkinson's disease	0.000375	0.00439	CbGeAlD
Clomipramine—CYP2D6—forebrain—Parkinson's disease	0.000362	0.00424	CbGeAlD
Clomipramine—SLC6A2—nervous system—Parkinson's disease	0.000359	0.0042	CbGeAlD
Clomipramine—SLC6A2—central nervous system—Parkinson's disease	0.000346	0.00405	CbGeAlD
Clomipramine—ADRA2A—medulla oblongata—Parkinson's disease	0.000338	0.00395	CbGeAlD
Clomipramine—HTR2A—cardiovascular system—Parkinson's disease	0.000336	0.00394	CbGeAlD
Clomipramine—HTR2C—brain—Parkinson's disease	0.000329	0.00385	CbGeAlD
Clomipramine—ALB—brain—Parkinson's disease	0.000321	0.00376	CbGeAlD
Clomipramine—SLC6A4—brain—Parkinson's disease	0.000312	0.00365	CbGeAlD
Clomipramine—HTR2B—brain—Parkinson's disease	0.000309	0.00362	CbGeAlD
Clomipramine—ADRA2A—midbrain—Parkinson's disease	0.000309	0.00361	CbGeAlD
Clomipramine—ADRA2A—spinal cord—Parkinson's disease	0.000301	0.00353	CbGeAlD
Clomipramine—ABCB1—embryo—Parkinson's disease	0.000295	0.00345	CbGeAlD
Clomipramine—HTR2A—medulla oblongata—Parkinson's disease	0.000287	0.00336	CbGeAlD
Clomipramine—SLC6A2—brain—Parkinson's disease	0.000275	0.00321	CbGeAlD
Clomipramine—ADRA2A—head—Parkinson's disease	0.000268	0.00313	CbGeAlD
Clomipramine—HTR2A—midbrain—Parkinson's disease	0.000263	0.00307	CbGeAlD
Clomipramine—ABCB1—forebrain—Parkinson's disease	0.000261	0.00305	CbGeAlD
Clomipramine—HTR2A—spinal cord—Parkinson's disease	0.000256	0.003	CbGeAlD
Clomipramine—ADRA2A—nervous system—Parkinson's disease	0.000254	0.00297	CbGeAlD
Clomipramine—ADRA2A—central nervous system—Parkinson's disease	0.000245	0.00286	CbGeAlD
Clomipramine—ADRA2A—cerebellum—Parkinson's disease	0.000239	0.0028	CbGeAlD
Clomipramine—HTR2A—head—Parkinson's disease	0.000228	0.00266	CbGeAlD
Clomipramine—Propericiazine—DRD1—Parkinson's disease	0.000225	0.0265	CrCbGaD
Clomipramine—ABCB1—cardiovascular system—Parkinson's disease	0.00022	0.00258	CbGeAlD
Clomipramine—HTR2A—nervous system—Parkinson's disease	0.000216	0.00253	CbGeAlD
Clomipramine—HTR2A—central nervous system—Parkinson's disease	0.000208	0.00243	CbGeAlD
Clomipramine—CYP2D6—head—Parkinson's disease	0.000208	0.00243	CbGeAlD
Clomipramine—HTR2A—cerebellum—Parkinson's disease	0.000203	0.00238	CbGeAlD
Clomipramine—CYP3A4—nervous system—Parkinson's disease	0.0002	0.00234	CbGeAlD
Clomipramine—CYP2D6—nervous system—Parkinson's disease	0.000197	0.0023	CbGeAlD
Clomipramine—ADRA2A—brain—Parkinson's disease	0.000194	0.00227	CbGeAlD
Clomipramine—CYP3A4—central nervous system—Parkinson's disease	0.000193	0.00225	CbGeAlD
Clomipramine—CYP2D6—central nervous system—Parkinson's disease	0.000189	0.00222	CbGeAlD
Clomipramine—ABCB1—medulla oblongata—Parkinson's disease	0.000188	0.0022	CbGeAlD
Clomipramine—CYP2D6—cerebellum—Parkinson's disease	0.000185	0.00217	CbGeAlD
Clomipramine—ABCB1—midbrain—Parkinson's disease	0.000172	0.00201	CbGeAlD
Clomipramine—ABCB1—spinal cord—Parkinson's disease	0.000168	0.00196	CbGeAlD
Clomipramine—HTR2A—brain—Parkinson's disease	0.000165	0.00193	CbGeAlD
Clomipramine—Triflupromazine—DRD1—Parkinson's disease	0.000156	0.0184	CrCbGaD
Clomipramine—CYP2D6—brain—Parkinson's disease	0.00015	0.00176	CbGeAlD
Clomipramine—ABCB1—head—Parkinson's disease	0.000149	0.00175	CbGeAlD
Clomipramine—Acepromazine—DRD1—Parkinson's disease	0.000144	0.017	CrCbGaD
Clomipramine—ABCB1—nervous system—Parkinson's disease	0.000142	0.00166	CbGeAlD
Clomipramine—Thioproperazine—DRD1—Parkinson's disease	0.000141	0.0166	CrCbGaD
Clomipramine—Pipotiazine—DRD1—Parkinson's disease	0.000139	0.0164	CrCbGaD
Clomipramine—Chlorphenamine—SLC6A3—Parkinson's disease	0.000138	0.0163	CrCbGaD
Clomipramine—ABCB1—central nervous system—Parkinson's disease	0.000136	0.00159	CbGeAlD
Clomipramine—Prochlorperazine—DRD3—Parkinson's disease	0.000135	0.0159	CrCbGaD
Clomipramine—ABCB1—cerebellum—Parkinson's disease	0.000133	0.00156	CbGeAlD
Clomipramine—Cyamemazine—HTR2A—Parkinson's disease	0.000122	0.0144	CrCbGaD
Clomipramine—Acepromazine—HTR1A—Parkinson's disease	0.00012	0.0141	CrCbGaD
Clomipramine—Thioproperazine—HTR1A—Parkinson's disease	0.000117	0.0138	CrCbGaD
Clomipramine—Carbinoxamine—CYP2E1—Parkinson's disease	0.000117	0.0137	CrCbGaD
Clomipramine—Propiomazine—DRD1—Parkinson's disease	0.000115	0.0136	CrCbGaD
Clomipramine—Pipotiazine—HTR1A—Parkinson's disease	0.000115	0.0136	CrCbGaD
Clomipramine—Thioridazine—HTR7—Parkinson's disease	0.000112	0.0132	CrCbGaD
Clomipramine—Chlorprothixene—DRD3—Parkinson's disease	0.000111	0.0131	CrCbGaD
Clomipramine—Triflupromazine—DRD2—Parkinson's disease	0.00011	0.013	CrCbGaD
Clomipramine—Chlorprothixene—DRD1—Parkinson's disease	0.000109	0.0129	CrCbGaD
Clomipramine—ABCB1—brain—Parkinson's disease	0.000108	0.00127	CbGeAlD
Clomipramine—Thioridazine—DRD1—Parkinson's disease	0.000103	0.0122	CrCbGaD
Clomipramine—Perphenazine—HTR7—Parkinson's disease	0.000103	0.0121	CrCbGaD
Clomipramine—Acepromazine—DRD2—Parkinson's disease	0.000102	0.012	CrCbGaD
Clomipramine—Methotrimeprazine—DRD3—Parkinson's disease	0.000101	0.0118	CrCbGaD
Clomipramine—Thioproperazine—DRD2—Parkinson's disease	9.94e-05	0.0117	CrCbGaD
Clomipramine—Methotrimeprazine—DRD1—Parkinson's disease	9.87e-05	0.0116	CrCbGaD
Clomipramine—Pipotiazine—DRD2—Parkinson's disease	9.78e-05	0.0115	CrCbGaD
Clomipramine—Trimipramine—SLC6A3—Parkinson's disease	9.57e-05	0.0113	CrCbGaD
Clomipramine—Perphenazine—DRD1—Parkinson's disease	9.48e-05	0.0112	CrCbGaD
Clomipramine—Prochlorperazine—DRD2—Parkinson's disease	9.35e-05	0.011	CrCbGaD
Clomipramine—Nortriptyline—HTR1A—Parkinson's disease	8.9e-05	0.0105	CrCbGaD
Clomipramine—Thioridazine—HTR1A—Parkinson's disease	8.58e-05	0.0101	CrCbGaD
Clomipramine—Carbinoxamine—CYP2D6—Parkinson's disease	8.56e-05	0.0101	CrCbGaD
Clomipramine—Promazine—DRD1—Parkinson's disease	8.55e-05	0.0101	CrCbGaD
Clomipramine—Trimipramine—HTR1A—Parkinson's disease	8.38e-05	0.00988	CrCbGaD
Clomipramine—Desipramine—SLC6A3—Parkinson's disease	8.37e-05	0.00986	CrCbGaD
Clomipramine—Chlorpromazine—HTR7—Parkinson's disease	8.15e-05	0.00961	CrCbGaD
Clomipramine—Propiomazine—DRD2—Parkinson's disease	8.13e-05	0.00958	CrCbGaD
Clomipramine—Imipramine—HTR7—Parkinson's disease	8.11e-05	0.00956	CrCbGaD
Clomipramine—Amitriptyline—HTR7—Parkinson's disease	8.06e-05	0.0095	CrCbGaD
Clomipramine—Doxepin—HTR1A—Parkinson's disease	7.99e-05	0.00941	CrCbGaD
Clomipramine—Trifluoperazine—HTR1A—Parkinson's disease	7.96e-05	0.00938	CrCbGaD
Clomipramine—Perphenazine—HTR1A—Parkinson's disease	7.88e-05	0.00928	CrCbGaD
Clomipramine—Acepromazine—HTR2A—Parkinson's disease	7.86e-05	0.00926	CrCbGaD
Clomipramine—Chlorprothixene—DRD2—Parkinson's disease	7.7e-05	0.00907	CrCbGaD
Clomipramine—Thioproperazine—HTR2A—Parkinson's disease	7.68e-05	0.00905	CrCbGaD
Clomipramine—Chlorpromazine—DRD3—Parkinson's disease	7.66e-05	0.00903	CrCbGaD
Clomipramine—Amitriptyline—DRD3—Parkinson's disease	7.58e-05	0.00893	CrCbGaD
Clomipramine—Pipotiazine—HTR2A—Parkinson's disease	7.56e-05	0.00891	CrCbGaD
Clomipramine—Nortriptyline—DRD2—Parkinson's disease	7.56e-05	0.0089	CrCbGaD
Clomipramine—Chlorpromazine—DRD1—Parkinson's disease	7.52e-05	0.00886	CrCbGaD
Clomipramine—Desipramine—HTR1A—Parkinson's disease	7.33e-05	0.00864	CrCbGaD
Clomipramine—Thioridazine—DRD2—Parkinson's disease	7.28e-05	0.00858	CrCbGaD
Clomipramine—Chlorphenamine—CYP2D6—Parkinson's disease	7.28e-05	0.00857	CrCbGaD
Clomipramine—Nortriptyline—CYP2E1—Parkinson's disease	7.27e-05	0.00857	CrCbGaD
Clomipramine—Trimipramine—DRD2—Parkinson's disease	7.12e-05	0.00838	CrCbGaD
Clomipramine—Imipramine—SLC6A3—Parkinson's disease	7.1e-05	0.00836	CrCbGaD
Clomipramine—Thioridazine—CYP2E1—Parkinson's disease	7.01e-05	0.00826	CrCbGaD
Clomipramine—Methotrimeprazine—DRD2—Parkinson's disease	6.96e-05	0.00819	CrCbGaD
Clomipramine—Flurazepam—CYP2E1—Parkinson's disease	6.92e-05	0.00815	CrCbGaD
Clomipramine—Pipotiazine—CYP2D6—Parkinson's disease	6.91e-05	0.00815	CrCbGaD
Clomipramine—Promethazine—DRD2—Parkinson's disease	6.85e-05	0.00807	CrCbGaD
Clomipramine—Doxepin—DRD2—Parkinson's disease	6.78e-05	0.00799	CrCbGaD
Clomipramine—Trifluoperazine—DRD2—Parkinson's disease	6.76e-05	0.00796	CrCbGaD
Clomipramine—Methotrimeprazine—CYP2E1—Parkinson's disease	6.69e-05	0.00789	CrCbGaD
Clomipramine—Perphenazine—DRD2—Parkinson's disease	6.69e-05	0.00788	CrCbGaD
Clomipramine—Prochlorperazine—CYP2D6—Parkinson's disease	6.61e-05	0.00778	CrCbGaD
Clomipramine—Propiomazine—HTR2A—Parkinson's disease	6.29e-05	0.00741	CrCbGaD
Clomipramine—Chlorpromazine—HTR1A—Parkinson's disease	6.25e-05	0.00736	CrCbGaD
Clomipramine—Desipramine—DRD2—Parkinson's disease	6.22e-05	0.00733	CrCbGaD
Clomipramine—Imipramine—HTR1A—Parkinson's disease	6.22e-05	0.00732	CrCbGaD
Clomipramine—Amitriptyline—HTR1A—Parkinson's disease	6.18e-05	0.00728	CrCbGaD
Clomipramine—Promazine—DRD2—Parkinson's disease	6.03e-05	0.0071	CrCbGaD
Clomipramine—Desipramine—CYP2E1—Parkinson's disease	5.99e-05	0.00706	CrCbGaD
Clomipramine—Chlorprothixene—HTR2A—Parkinson's disease	5.95e-05	0.00701	CrCbGaD
Clomipramine—Nortriptyline—HTR2A—Parkinson's disease	5.84e-05	0.00688	CrCbGaD
Clomipramine—Thioridazine—HTR2A—Parkinson's disease	5.63e-05	0.00663	CrCbGaD
Clomipramine—Triflupromazine—ABCB1—Parkinson's disease	5.55e-05	0.00654	CrCbGaD
Clomipramine—Trimipramine—HTR2A—Parkinson's disease	5.5e-05	0.00648	CrCbGaD
Clomipramine—Diazepam—CYP2E1—Parkinson's disease	5.5e-05	0.00648	CrCbGaD
Clomipramine—Methotrimeprazine—HTR2A—Parkinson's disease	5.37e-05	0.00633	CrCbGaD
Clomipramine—Nortriptyline—CYP2D6—Parkinson's disease	5.34e-05	0.00629	CrCbGaD
Clomipramine—Chlorpromazine—DRD2—Parkinson's disease	5.3e-05	0.00625	CrCbGaD
Clomipramine—Promethazine—HTR2A—Parkinson's disease	5.29e-05	0.00624	CrCbGaD
Clomipramine—Imipramine—DRD2—Parkinson's disease	5.28e-05	0.00622	CrCbGaD
Clomipramine—Amitriptyline—DRD2—Parkinson's disease	5.24e-05	0.00618	CrCbGaD
Clomipramine—Doxepin—HTR2A—Parkinson's disease	5.24e-05	0.00617	CrCbGaD
Clomipramine—Trifluoperazine—HTR2A—Parkinson's disease	5.22e-05	0.00615	CrCbGaD
Clomipramine—Perphenazine—HTR2A—Parkinson's disease	5.17e-05	0.00609	CrCbGaD
Clomipramine—Thioridazine—CYP2D6—Parkinson's disease	5.15e-05	0.00607	CrCbGaD
Clomipramine—Chlorpromazine—CYP2E1—Parkinson's disease	5.11e-05	0.00602	CrCbGaD
Clomipramine—Imipramine—CYP2E1—Parkinson's disease	5.08e-05	0.00598	CrCbGaD
Clomipramine—Amitriptyline—CYP2E1—Parkinson's disease	5.05e-05	0.00595	CrCbGaD
Clomipramine—Trimipramine—CYP2D6—Parkinson's disease	5.03e-05	0.00592	CrCbGaD
Clomipramine—Clobazam—ABCB1—Parkinson's disease	4.94e-05	0.00582	CrCbGaD
Clomipramine—Methotrimeprazine—CYP2D6—Parkinson's disease	4.91e-05	0.00579	CrCbGaD
Clomipramine—Promethazine—CYP2D6—Parkinson's disease	4.84e-05	0.0057	CrCbGaD
Clomipramine—Desipramine—HTR2A—Parkinson's disease	4.81e-05	0.00567	CrCbGaD
Clomipramine—Doxepin—CYP2D6—Parkinson's disease	4.79e-05	0.00565	CrCbGaD
Clomipramine—Perphenazine—CYP2D6—Parkinson's disease	4.72e-05	0.00557	CrCbGaD
Clomipramine—Promazine—HTR2A—Parkinson's disease	4.66e-05	0.00549	CrCbGaD
Clomipramine—Desipramine—CYP2D6—Parkinson's disease	4.4e-05	0.00518	CrCbGaD
Clomipramine—Chlorpromazine—HTR2A—Parkinson's disease	4.1e-05	0.00483	CrCbGaD
Clomipramine—Imipramine—HTR2A—Parkinson's disease	4.08e-05	0.0048	CrCbGaD
Clomipramine—Amitriptyline—HTR2A—Parkinson's disease	4.05e-05	0.00477	CrCbGaD
Clomipramine—Chlorprothixene—ABCB1—Parkinson's disease	3.89e-05	0.00458	CrCbGaD
Clomipramine—Chlorpromazine—CYP2D6—Parkinson's disease	3.75e-05	0.00442	CrCbGaD
Clomipramine—Imipramine—CYP2D6—Parkinson's disease	3.73e-05	0.00439	CrCbGaD
Clomipramine—Amitriptyline—CYP2D6—Parkinson's disease	3.71e-05	0.00437	CrCbGaD
Clomipramine—Flurazepam—ABCB1—Parkinson's disease	3.63e-05	0.00427	CrCbGaD
Clomipramine—Trimipramine—ABCB1—Parkinson's disease	3.59e-05	0.00423	CrCbGaD
Clomipramine—Promethazine—ABCB1—Parkinson's disease	3.46e-05	0.00407	CrCbGaD
Clomipramine—Doxepin—ABCB1—Parkinson's disease	3.42e-05	0.00403	CrCbGaD
Clomipramine—Trifluoperazine—ABCB1—Parkinson's disease	3.41e-05	0.00402	CrCbGaD
Clomipramine—Desipramine—ABCB1—Parkinson's disease	3.14e-05	0.0037	CrCbGaD
Clomipramine—Diazepam—ABCB1—Parkinson's disease	2.88e-05	0.0034	CrCbGaD
Clomipramine—Chlorpromazine—ABCB1—Parkinson's disease	2.68e-05	0.00315	CrCbGaD
Clomipramine—Imipramine—ABCB1—Parkinson's disease	2.66e-05	0.00314	CrCbGaD
Clomipramine—Amitriptyline—ABCB1—Parkinson's disease	2.65e-05	0.00312	CrCbGaD
Clomipramine—HTR2B—Signaling Pathways—ADRBK1—Parkinson's disease	1.55e-05	0.000117	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.53e-05	0.000116	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—GRM5—Parkinson's disease	1.53e-05	0.000116	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—INSR—Parkinson's disease	1.52e-05	0.000115	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.5e-05	0.000113	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—OMD—Parkinson's disease	1.5e-05	0.000113	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—HTR2A—Parkinson's disease	1.5e-05	0.000113	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—DRD2—Parkinson's disease	1.5e-05	0.000113	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HTR7—Parkinson's disease	1.5e-05	0.000113	CbGpPWpGaD
Clomipramine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	1.49e-05	0.000113	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—DDC—Parkinson's disease	1.48e-05	0.000111	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—FGF20—Parkinson's disease	1.47e-05	0.000111	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—DDC—Parkinson's disease	1.44e-05	0.000109	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—FGB—Parkinson's disease	1.44e-05	0.000108	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—HTR2A—Parkinson's disease	1.43e-05	0.000108	CbGpPWpGaD
Clomipramine—ABCB1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	1.43e-05	0.000108	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ADORA2A—Parkinson's disease	1.43e-05	0.000108	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HTR1A—Parkinson's disease	1.43e-05	0.000108	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—EDN1—Parkinson's disease	1.42e-05	0.000108	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.42e-05	0.000107	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—EDN1—Parkinson's disease	1.42e-05	0.000107	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—TAC1—Parkinson's disease	1.41e-05	0.000106	CbGpPWpGaD
Clomipramine—ALB—Metabolism—PLA2G6—Parkinson's disease	1.4e-05	0.000106	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GSTA4—Parkinson's disease	1.39e-05	0.000105	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—APOE—Parkinson's disease	1.39e-05	0.000105	CbGpPWpGaD
Clomipramine—ALB—Metabolism—MAOB—Parkinson's disease	1.38e-05	0.000105	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—DRD1—Parkinson's disease	1.38e-05	0.000104	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.38e-05	0.000104	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IGF2—Parkinson's disease	1.37e-05	0.000104	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GSTA4—Parkinson's disease	1.36e-05	0.000103	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—DDC—Parkinson's disease	1.36e-05	0.000103	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.36e-05	0.000102	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—FGF20—Parkinson's disease	1.34e-05	0.000101	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—DRD3—Parkinson's disease	1.34e-05	0.000101	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IGF1R—Parkinson's disease	1.33e-05	0.0001	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—INSR—Parkinson's disease	1.32e-05	9.97e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.32e-05	9.95e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—EDN1—Parkinson's disease	1.31e-05	9.92e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CYP2D6—Parkinson's disease	1.3e-05	9.85e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ADORA2A—Parkinson's disease	1.3e-05	9.82e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—EDN1—Parkinson's disease	1.29e-05	9.77e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.28e-05	9.68e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CTGF—Parkinson's disease	1.28e-05	9.66e-05	CbGpPWpGaD
Clomipramine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	1.28e-05	9.66e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	1.25e-05	9.48e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IGF2—Parkinson's disease	1.25e-05	9.48e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—ADRBK1—Parkinson's disease	1.25e-05	9.42e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—FGB—Parkinson's disease	1.25e-05	9.42e-05	CbGpPWpGaD
Clomipramine—ADRA2A—GPCR downstream signaling—HTR2A—Parkinson's disease	1.25e-05	9.41e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—MAOB—Parkinson's disease	1.24e-05	9.39e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HTR1A—Parkinson's disease	1.24e-05	9.37e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—PLA2G6—Parkinson's disease	1.22e-05	9.25e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—TAC1—Parkinson's disease	1.22e-05	9.23e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IGF1R—Parkinson's disease	1.21e-05	9.17e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—MAOB—Parkinson's disease	1.21e-05	9.16e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.21e-05	9.14e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GBA—Parkinson's disease	1.21e-05	9.14e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—DBH—Parkinson's disease	1.21e-05	9.14e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—DRD2—Parkinson's disease	1.21e-05	9.13e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HTR7—Parkinson's disease	1.21e-05	9.13e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—NGF—Parkinson's disease	1.21e-05	9.12e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—INSR—Parkinson's disease	1.2e-05	9.07e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—EDN1—Parkinson's disease	1.2e-05	9.06e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—DRD1—Parkinson's disease	1.2e-05	9.05e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CYP2E1—Parkinson's disease	1.19e-05	9e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—INS—Parkinson's disease	1.19e-05	8.99e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.18e-05	8.93e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—NQO1—Parkinson's disease	1.18e-05	8.9e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—TH—Parkinson's disease	1.16e-05	8.78e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—DRD3—Parkinson's disease	1.16e-05	8.76e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.15e-05	8.72e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—DDC—Parkinson's disease	1.15e-05	8.69e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—HTR2A—Parkinson's disease	1.15e-05	8.68e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.14e-05	8.63e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—FGB—Parkinson's disease	1.13e-05	8.57e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—HTR2A—Parkinson's disease	1.13e-05	8.55e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HTR1A—Parkinson's disease	1.13e-05	8.52e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—CYCS—Parkinson's disease	1.11e-05	8.43e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—TAC1—Parkinson's disease	1.11e-05	8.39e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—NGF—Parkinson's disease	1.1e-05	8.32e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—DRD1—Parkinson's disease	1.09e-05	8.23e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTA4—Parkinson's disease	1.09e-05	8.2e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—ADRBK1—Parkinson's disease	1.08e-05	8.18e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.07e-05	8.1e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—APOE—Parkinson's disease	1.07e-05	8.07e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—DRD3—Parkinson's disease	1.06e-05	7.97e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—HTR7—Parkinson's disease	1.05e-05	7.93e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—DRD2—Parkinson's disease	1.05e-05	7.93e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—HTR2A—Parkinson's disease	1.05e-05	7.92e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CYP2D6—Parkinson's disease	1.03e-05	7.77e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IGF2—Parkinson's disease	1.01e-05	7.65e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CTGF—Parkinson's disease	1.01e-05	7.63e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—COMT—Parkinson's disease	9.87e-06	7.46e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—ADRBK1—Parkinson's disease	9.85e-06	7.45e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GSTP1—Parkinson's disease	9.83e-06	7.43e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—MAOA—Parkinson's disease	9.8e-06	7.41e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IGF1R—Parkinson's disease	9.79e-06	7.39e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	9.77e-06	7.39e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—APOE—Parkinson's disease	9.75e-06	7.37e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—HMOX1—Parkinson's disease	9.69e-06	7.32e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—MAOB—Parkinson's disease	9.68e-06	7.31e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—EDN1—Parkinson's disease	9.67e-06	7.31e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—DRD2—Parkinson's disease	9.54e-06	7.21e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HTR7—Parkinson's disease	9.54e-06	7.21e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CYP2E1—Parkinson's disease	9.4e-06	7.11e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—ABCB1—Parkinson's disease	9.3e-06	7.03e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—NQO1—Parkinson's disease	9.3e-06	7.03e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	9.23e-06	6.98e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	9.21e-06	6.96e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—TH—Parkinson's disease	9.16e-06	6.93e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—INS—Parkinson's disease	9.12e-06	6.89e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CTGF—Parkinson's disease	9.06e-06	6.85e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GSTM1—Parkinson's disease	9.03e-06	6.82e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYP2D6—Parkinson's disease	9.01e-06	6.81e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—NGF—Parkinson's disease	8.89e-06	6.71e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—DDC—Parkinson's disease	8.87e-06	6.7e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—CASP3—Parkinson's disease	8.86e-06	6.69e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CTGF—Parkinson's disease	8.84e-06	6.68e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—CYCS—Parkinson's disease	8.8e-06	6.65e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling by GPCR—IL6—Parkinson's disease	8.8e-06	6.65e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IGF2—Parkinson's disease	8.79e-06	6.64e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—GPX1—Parkinson's disease	8.65e-06	6.54e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IGF1R—Parkinson's disease	8.5e-06	6.42e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—HTR2A—Parkinson's disease	8.46e-06	6.39e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	8.44e-06	6.38e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—EDN1—Parkinson's disease	8.4e-06	6.35e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	8.38e-06	6.33e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—NQO1—Parkinson's disease	8.35e-06	6.31e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CTGF—Parkinson's disease	8.33e-06	6.3e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—INS—Parkinson's disease	8.33e-06	6.29e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYP2E1—Parkinson's disease	8.24e-06	6.23e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—TH—Parkinson's disease	8.23e-06	6.22e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—NQO1—Parkinson's disease	8.15e-06	6.16e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—MAPK8—Parkinson's disease	8.14e-06	6.15e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—TH—Parkinson's disease	8.03e-06	6.07e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF2—Parkinson's disease	8e-06	6.04e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—MTHFR—Parkinson's disease	7.98e-06	6.03e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—CYCS—Parkinson's disease	7.9e-06	5.97e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—APOE—Parkinson's disease	7.86e-06	5.94e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—COMT—Parkinson's disease	7.79e-06	5.89e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	7.76e-06	5.87e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GSTP1—Parkinson's disease	7.76e-06	5.86e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—MAOA—Parkinson's disease	7.74e-06	5.85e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	7.73e-06	5.84e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—NGF—Parkinson's disease	7.72e-06	5.83e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—CYCS—Parkinson's disease	7.71e-06	5.83e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—NQO1—Parkinson's disease	7.68e-06	5.8e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—HMOX1—Parkinson's disease	7.65e-06	5.78e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	7.64e-06	5.77e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—TH—Parkinson's disease	7.57e-06	5.72e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	7.54e-06	5.7e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MAOB—Parkinson's disease	7.47e-06	5.64e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—APOE—Parkinson's disease	7.43e-06	5.61e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—ABCB1—Parkinson's disease	7.34e-06	5.55e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—CYCS—Parkinson's disease	7.26e-06	5.49e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	7.19e-06	5.43e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GSTM1—Parkinson's disease	7.13e-06	5.39e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CTGF—Parkinson's disease	7.06e-06	5.33e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	7.02e-06	5.3e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—COMT—Parkinson's disease	6.99e-06	5.29e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GSTP1—Parkinson's disease	6.96e-06	5.26e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—MAOA—Parkinson's disease	6.95e-06	5.25e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—HMOX1—Parkinson's disease	6.87e-06	5.19e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—APOE—Parkinson's disease	6.83e-06	5.16e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—COMT—Parkinson's disease	6.83e-06	5.16e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—GPX1—Parkinson's disease	6.82e-06	5.16e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GSTP1—Parkinson's disease	6.79e-06	5.14e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—CASP3—Parkinson's disease	6.79e-06	5.13e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—MAOA—Parkinson's disease	6.78e-06	5.12e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling by GPCR—IL6—Parkinson's disease	6.75e-06	5.1e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—INS—Parkinson's disease	6.72e-06	5.08e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—HMOX1—Parkinson's disease	6.7e-06	5.06e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	6.68e-06	5.05e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—ABCB1—Parkinson's disease	6.59e-06	4.98e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	6.58e-06	4.97e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—NQO1—Parkinson's disease	6.5e-06	4.92e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—COMT—Parkinson's disease	6.43e-06	4.86e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—TH—Parkinson's disease	6.41e-06	4.84e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	6.4e-06	4.84e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GSTM1—Parkinson's disease	6.4e-06	4.83e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—MAOA—Parkinson's disease	6.39e-06	4.83e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Metabolism—INS—Parkinson's disease	6.35e-06	4.8e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	6.31e-06	4.77e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—MTHFR—Parkinson's disease	6.3e-06	4.76e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GSTM1—Parkinson's disease	6.24e-06	4.72e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—MAPK8—Parkinson's disease	6.24e-06	4.72e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	6.21e-06	4.69e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	6.2e-06	4.69e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	6.16e-06	4.65e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—CYCS—Parkinson's disease	6.15e-06	4.65e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—GPX1—Parkinson's disease	6.13e-06	4.63e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	6.06e-06	4.58e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—GPX1—Parkinson's disease	5.98e-06	4.52e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	5.88e-06	4.45e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—APOE—Parkinson's disease	5.86e-06	4.43e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—INS—Parkinson's disease	5.83e-06	4.41e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	5.7e-06	4.31e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—MTHFR—Parkinson's disease	5.65e-06	4.27e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—GPX1—Parkinson's disease	5.63e-06	4.26e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	5.55e-06	4.19e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—MTHFR—Parkinson's disease	5.52e-06	4.17e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—COMT—Parkinson's disease	5.45e-06	4.12e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CTGF—Parkinson's disease	5.45e-06	4.12e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTP1—Parkinson's disease	5.42e-06	4.1e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—MAOA—Parkinson's disease	5.41e-06	4.09e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—HMOX1—Parkinson's disease	5.35e-06	4.04e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—INS—Parkinson's disease	5.31e-06	4.01e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—APOE—Parkinson's disease	5.26e-06	3.98e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	5.2e-06	3.93e-05	CbGpPWpGaD
Clomipramine—HRH2—Signaling Pathways—IL6—Parkinson's disease	5.2e-06	3.93e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—APOE—Parkinson's disease	5.14e-06	3.88e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—ABCB1—Parkinson's disease	5.13e-06	3.88e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	5.08e-06	3.84e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—NQO1—Parkinson's disease	5.02e-06	3.79e-05	CbGpPWpGaD
Clomipramine—ALB—Metabolism—INS—Parkinson's disease	5.01e-06	3.79e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	5e-06	3.78e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GSTM1—Parkinson's disease	4.98e-06	3.77e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	4.97e-06	3.76e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—TH—Parkinson's disease	4.95e-06	3.74e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—APOE—Parkinson's disease	4.84e-06	3.66e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—GPX1—Parkinson's disease	4.77e-06	3.61e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—CYCS—Parkinson's disease	4.75e-06	3.59e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	4.6e-06	3.47e-05	CbGpPWpGaD
Clomipramine—CYP2C19—Metabolism—INS—Parkinson's disease	4.5e-06	3.4e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—MTHFR—Parkinson's disease	4.41e-06	3.33e-05	CbGpPWpGaD
Clomipramine—ABCB1—Metabolism—INS—Parkinson's disease	4.39e-06	3.32e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	4.34e-06	3.28e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	4.32e-06	3.26e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—COMT—Parkinson's disease	4.21e-06	3.18e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	4.19e-06	3.16e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MAOA—Parkinson's disease	4.18e-06	3.16e-05	CbGpPWpGaD
Clomipramine—CYP2D6—Metabolism—INS—Parkinson's disease	4.14e-06	3.13e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	4.13e-06	3.12e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—APOE—Parkinson's disease	4.1e-06	3.1e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	3.99e-06	3.02e-05	CbGpPWpGaD
Clomipramine—HTR6—Signaling Pathways—IL6—Parkinson's disease	3.99e-06	3.01e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	3.96e-06	2.99e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	3.95e-06	2.99e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	3.93e-06	2.97e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	3.85e-06	2.91e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—GPX1—Parkinson's disease	3.68e-06	2.78e-05	CbGpPWpGaD
Clomipramine—HTR2B—Signaling Pathways—IL6—Parkinson's disease	3.64e-06	2.75e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	3.63e-06	2.74e-05	CbGpPWpGaD
Clomipramine—CYP1A2—Metabolism—INS—Parkinson's disease	3.5e-06	2.65e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.4e-06	2.57e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—APOE—Parkinson's disease	3.17e-06	2.39e-05	CbGpPWpGaD
Clomipramine—HTR2C—Signaling Pathways—IL6—Parkinson's disease	2.94e-06	2.22e-05	CbGpPWpGaD
Clomipramine—CYP3A4—Metabolism—INS—Parkinson's disease	2.7e-06	2.04e-05	CbGpPWpGaD
Clomipramine—HTR2A—Signaling Pathways—IL6—Parkinson's disease	2.55e-06	1.93e-05	CbGpPWpGaD
Clomipramine—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	2.32e-06	1.75e-05	CbGpPWpGaD
